These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Saxagliptin Alleviates Lipopolysaccharide-Induced Acute Lung Injury via Regulating the Nrf-2/HO-1 and NF-κB Pathways. Guo K, Jin F. J Invest Surg; 2021 Jul 01; 34(7):695-702. PubMed ID: 31694415 [Abstract] [Full Text] [Related]
17. Paritaprevir ameliorates experimental acute lung injury in vitro and in vivo. Ren R, Wang X, Xu Z, Jiang W. Arch Pharm Res; 2023 Jun 01; 46(6):564-572. PubMed ID: 37306915 [Abstract] [Full Text] [Related]
18. Unfractionated heparin ameliorates pulmonary microvascular endothelial barrier dysfunction via microtubule stabilization in acute lung injury. Mu S, Liu Y, Jiang J, Ding R, Li X, Li X, Ma X. Respir Res; 2018 Nov 15; 19(1):220. PubMed ID: 30442128 [Abstract] [Full Text] [Related]
19. The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Directly Enhances the Contractile Recovery of Mouse Hearts at a Concentration Equivalent to that Achieved with Standard Dosing in Humans. Batchu SN, Yerra VG, Liu Y, Advani SL, Klein T, Advani A. Int J Mol Sci; 2020 Aug 11; 21(16):. PubMed ID: 32796688 [Abstract] [Full Text] [Related]